FHIR © HL7.org  |  FHIRsmith 0.14.2  |  Server Home  |  XIG Home  |  XIG Stats  | 

FHIR IG analytics

Resources - All Kinds

277,663 resources (JSON | CSV)

Type:
Text: Package: Only Show Used

By Version

By Authority

By Realm

 

Start Prev Rows 69400 - 69600 Next

PackageVersionIdentityName/TitleStatusFMMWGDateRealmAuthUsage #
hl7.fhir.uv.cpg.r4bR4BGraphDefinition/GraphDefinition-chf-casesummarydefinition.json
hl7.fhir.uv.cpg.r4R4GraphDefinition/GraphDefinition-chf-caseplansummarydefinition.json
hl7.fhir.uv.cpg.r4R4GraphDefinition/GraphDefinition-chf-casesummarydefinition.json
hl7.fhir.uv.cpgR4GraphDefinition/GraphDefinition-chf-caseplansummarydefinition.jsonCHFCasePlanSummaryDefinitionactiveuvhl7
hl7.fhir.uv.cpgR4GraphDefinition/GraphDefinition-chf-casesummarydefinition.jsonCHFCaseSummaryDefinitionactiveuvhl7
hl7.fhir.uv.crmiR4GraphDefinition/GraphDefinition-publishable-example.jsonPublishableGraphDefinitionExampledraft2021-02uvhl7
hl7.fhir.uv.crmiR4GraphDefinition/GraphDefinition-shareable-example.jsonShareableGraphDefinitionExampledraft2021-02uvhl7
uk.nhsengland.genomics.r4R4GraphDefinition/GraphDefinition-Genomics-Test-Order.jsonGenomicsTestOrderdraft2026-03
uk.nhsengland.genomics.r4R4GraphDefinition/GraphDefinition-Genomics-Test-Result.jsonGenomicsTestResultdraft2026-03
uk.nhsengland.genomics.r4R4GraphDefinition/GraphDefinition-Genomics-ResultsGroup-Example.jsonGenomicsResultsGroupdraft2026-03
uk.nhsengland.genomics.r4R4GraphDefinition/GraphDefinition-Genomics-TestOrdersGroup-Example.jsonGenomicsTestOrdersGroupdraft2026-03
hl7.fhir.be.referralR4GraphDefinition/GraphDefinition-full-referral-prescription.jsonFullReferralPrescriptionactive12024-09behl7
hl7.fhir.uv.api-incubatorR6GraphDefinition/GraphDefinition-example.jsonDocument Generation Templatedraft2015-08uvhl7
hl7.fhir.us.hai-ltcfR4Group/Group-hai-ltcf-group-1.json
hl7.fhir.uv.cg-incubatorR6Group/Group-groupDenovoFamily.json
hl7.fhir.uv.cqlR4Group/Group-ANCCohort.json
hl7.fhir.uv.cqlR4Group/Group-ANCCohortDefinition.json
hl7.fhir.us.medmorph-research-dexR4Group/Group-group-example-research.json
hl7.fhir.us.mcodeR4Group/Group-group-mcode-patients.json
hl7.fhir.us.cdmhR4Group/Group-example.json
hl7.fhir.uv.cpgR4Group/Group-chf-groupdefinition.json
hl7.fhir.uv.cpgR4Group/Group-chf-scenario1-group.json
hl7.fhir.us.davinci-raR4Group/Group-ra-group01.json
hl7.fhir.us.davinci-raR4Group/Group-ra-group02.json
hl7.fhir.uv.emedicinal-product-infoR5Group/Group-group-diflucan-adult.json
hl7.fhir.uv.emedicinal-product-infoR5Group/Group-group-diflucan-renal.json
hl7.fhir.uv.emedicinal-product-infoR5Group/Group-group-epi-type3-example-adult-men.json
hl7.fhir.uv.emedicinal-product-infoR5Group/Group-group-epi-type3-example-adult-women.json
hl7.fhir.uv.emedicinal-product-infoR5Group/Group-group-epi-type3-example-children.json
hl7.fhir.us.sdoh-clinicalcareR4Group/Group-SDOHCC-GroupSDOHPatientsForPayerExample.json
uz.dhp.coreR5Group/Group-example-diabetes-screening-target-group.json
uz.dhp.coreR5Group/Group-example-measles-vaccinated-group.json
hl7.fhir.uv.bulkdataR4Group/Group-BulkCohortGroupExample.json
hl7.fhir.uv.crmiR4Group/Group-ExampleCohortDefinition.json
hl7.fhir.uv.crmiR4Group/Group-definition-example.json
hl7.fhir.uv.crmiR4Group/Group-publishable-example.json
hl7.fhir.uv.crmiR4Group/Group-shareable-example.json
hl7.fhir.uv.crmiR4Group/Group-testcase-example.json
hl7.fhir.uv.deqmR4Group/Group-gaps-subject-group01.json
hl7.fhir.uv.deqmR4Group/Group-group01.json
hl7.fhir.uv.deqmR4Group/Group-group02.json
hl7.fhir.us.davinci-vbprR4Group/Group-everyhospital-group.json
hl7.fhir.us.davinci-vbprR4Group/Group-goodhealth-group.json
hl7.fhir.us.davinci-pdexR4Group/Group-07e72a15407547bf9d03f522aa536a72.1.json
hl7.fhir.us.davinci-pdexR4Group/Group-Example-PDex-Provider-Group.json
hl7.fhir.us.davinci-pdexR4Group/Group-example-pdex-member-consent-constraint-group.json
hl7.fhir.us.davinci-pdexR4Group/Group-example-pdex-member-no-match-group.json
hl7.fhir.us.davinci-pdexR4Group/Group-example-pdex-treatment-relationship-group.json
hl7.fhir.us.davinci-pdexR4Group/Group-example-provider-consent-constrained-group.json
hl7.fhir.us.davinci-pdexR4Group/Group-example-provider-matched-group.json
hl7.fhir.us.davinci-pdexR4Group/Group-example-provider-nomatch-group.json
hl7.fhir.us.davinci-pdexR4Group/Group-member-opt-out-group-001.json
hl7.fhir.us.haiR4Group/Group-hai-group-1.json
fhir.gdxR4Group/Group-PrenatalGroupPatientFemaleandPatientMale.json
hl7.fhir.us.ph-libraryR4Group/Group-us-ph-survey-practitioner-group-example.json
hl7.fhir.us.davinci-atrR4Group/Group-davincipatientlistexample.json
hl7.fhir.us.davinci-atrR4Group/Group-fullexample.json
hl7.fhir.uv.ebmR6Group/Group-438155.json
hl7.fhir.uv.ebmR6Group/Group-568026.json
hl7.fhir.uv.clinical-study-protocolR6Group/Group-DIBASY-Eligibility.json
hl7.fhir.uv.clinical-study-protocolR6Group/Group-JPMA0001-Criteria-JPN.json
hl7.fhir.us.ndhR4Group/Group-BehavioralHealthGroupAtBurrClinic.json
ihe.iti.pcfR4Group/Group-ex-privilegedUsers.json
hl7.fhir.us.davinci-ra.r4R4Group/Group-ra-group01.json
hl7.fhir.us.davinci-ra.r4R4Group/Group-ra-group02.json
hl7.fhir.uv.crmi.r4R4Group/Group-definition-example.json
hl7.fhir.uv.crmi.r4R4Group/Group-publishable-example.json
hl7.fhir.uv.crmi.r4R4Group/Group-shareable-example.json
hl7.fhir.uv.crmi.r4R4Group/Group-testcase-example.json
de.nfdi4health.mdsR4Group/Group-InstanceOfGroupActualSHIP.json
de.nfdi4health.mdsR4Group/Group-InstanceOfGroupActualSPOVID.json
de.nfdi4health.mdsR4Group/Group-InstanceOfGroupEligibilityHKR.json
de.nfdi4health.mdsR4Group/Group-InstanceOfGroupEligibilitySHIP.json
de.nfdi4health.mdsR4Group/Group-InstanceOfGroupEligibilitySPOVID.json
hl7.fhir.us.davinci-ra.r4bR4BGroup/Group-ra-group01.json
hl7.fhir.us.davinci-ra.r4bR4BGroup/Group-ra-group02.json
hl7.fhir.us.ph-library.r4R4Group/Group-us-ph-survey-practitioner-group-example.json
hl7.fhir.us.sdoh-clinicalcare.r4bR4BGroup/Group-SDOHCC-GroupSDOHPatientsForPayerExample.json
hl7.fhir.us.mcode.r4bR4BGroup/Group-group-mcode-patients.json
hl7.fhir.us.mcode.r4R4Group/Group-group-mcode-patients.json
hl7.fhir.us.davinci-deqmR4Group/Group-gaps-subject-group01.json
hl7.fhir.us.davinci-deqmR4Group/Group-group01.json
hl7.fhir.dk.coreR4Group/Group-BerggrenFamily.json
hl7.fhir.dk.coreR4Group/Group-JensenFamily.json
hl7.fhir.dk.coreR4Group/Group-LauridsenFamily.json
hl7.fhir.dk.coreR4Group/Group-LevendefodtTwins2016.json
hl7.fhir.dk.coreR4Group/Group-LevendefodtTwins2024.json
hl7.fhir.dk.coreR4Group/Group-MosebryggerssenFamily.json
hl7.fhir.us.hai.r4bR4BGroup/Group-hai-group-1.json
hl7.fhir.uv.crmi.r4bR4BGroup/Group-definition-example.json
hl7.fhir.uv.crmi.r4bR4BGroup/Group-publishable-example.json
hl7.fhir.uv.crmi.r4bR4BGroup/Group-shareable-example.json
hl7.fhir.uv.crmi.r4bR4BGroup/Group-testcase-example.json
hl7.fhir.us.davinci-deqm.r4R4Group/Group-gaps-subject-group01.json
hl7.fhir.us.davinci-deqm.r4R4Group/Group-group01.json
hl7.fhir.us.hai.r4R4Group/Group-hai-group-1.json
hl7.fhir.us.ph-library.r4bR4BGroup/Group-us-ph-survey-practitioner-group-example.json
hl7.fhir.us.hai-ltcf.r4R4Group/Group-hai-ltcf-group-1.json
hl7.fhir.us.davinci-atr.r4R4Group/Group-davincipatientlistexample.json
hl7.fhir.us.davinci-atr.r4R4Group/Group-fullexample.json
hl7.fhir.uv.bulkdata.r4R4Group/Group-BulkCohortGroupExample.json
ca.on.health.idmsR5Group/IDMS-EXAMPLE-GROUP-CONTACT-LIST.json
ca.on.health.idmsR5Group/IDMS-GROUP-EXAMPLE.json
eu.miabis.r4R4Group/Group-NetworkInstance.json
eu.miabis.r4R4Group/Group-example-collection-group.json
il.core.fhir.r4R4Group/Group-101.json
hl7.fhir.us.hai-ltcf.r4bR4BGroup/Group-hai-ltcf-group-1.json
hl7.fhir.fr.analyse-pharmaR4Group/Group-InLine-patient-group-01.json
hl7.fhir.us.davinci-atr.r4bR4BGroup/Group-davincipatientlistexample.json
hl7.fhir.us.davinci-atr.r4bR4BGroup/Group-fullexample.json
de.medizininformatikinitiative.kerndatensatz.mtbR4Group/Group-mii-exa-mtb-study-cldn6-comparison-group-0.json
de.medizininformatikinitiative.kerndatensatz.mtbR4Group/Group-mii-exa-mtb-study-cldn6-comparison-group-1.json
de.medizininformatikinitiative.kerndatensatz.mtbR4Group/Group-mii-exa-mtb-study-cldn6-eligibility-criteria-age-groups.json
de.medizininformatikinitiative.kerndatensatz.mtbR4Group/Group-mii-exa-mtb-study-cldn6-eligibility-criteria.json
hl7.fhir.uv.cpg.r4bR4BGroup/Group-chf-groupdefinition.json
hl7.fhir.uv.cpg.r4bR4BGroup/Group-chf-scenario1-group.json
hl7.fhir.us.davinci-pdex.r4R4Group/Group-07e72a15407547bf9d03f522aa536a72.1.json
hl7.fhir.us.davinci-pdex.r4R4Group/Group-Example-PDex-Provider-Group.json
hl7.fhir.us.davinci-pdex.r4R4Group/Group-example-pdex-member-consent-constraint-group.json
hl7.fhir.us.davinci-pdex.r4R4Group/Group-example-pdex-member-no-match-group.json
hl7.fhir.uv.bulkdata.r4bR4BGroup/Group-BulkCohortGroupExample.json
de.netzwerk-universitaetsmedizin.ebm-cpgR5Group/Group-ExampleEvidenceSynthesisCohorts.json
de.netzwerk-universitaetsmedizin.ebm-cpgR5Group/Group-ExampleStudyCohort.json
de.netzwerk-universitaetsmedizin.ebm-cpgR5Group/Group-StudyCohortCorticosteroidsCOVID19.json
uk.nhsengland.genomics.r4R4Group/Group-FamilyPedigreeRepresentation-Example.json
ca.on.health.idms.agreementmvpR5Group/Group-739d668f-537b-4bef-b546-43a9ee70c9ea.json
ca.on.health.idms.agreementmvpR5Group/IDMS-EXAMPLE-GROUP-CONTACT-LIST.json
ca.on.health.idms.agreementmvpR5Group/IDMS-GROUP-EXAMPLE.json
hl7.fhir.us.sdoh-clinicalcare.r4R4Group/Group-SDOHCC-GroupSDOHPatientsForPayerExample.json
hl7.fhir.us.davinci-pdex.r4bR4BGroup/Group-07e72a15407547bf9d03f522aa536a72.1.json
hl7.fhir.us.davinci-pdex.r4bR4BGroup/Group-Example-PDex-Provider-Group.json
hl7.fhir.us.davinci-pdex.r4bR4BGroup/Group-example-pdex-member-consent-constraint-group.json
hl7.fhir.us.davinci-pdex.r4bR4BGroup/Group-example-pdex-member-no-match-group.json
hl7.fhir.us.davinci-deqm.r4bR4BGroup/Group-gaps-subject-group01.json
hl7.fhir.us.davinci-deqm.r4bR4BGroup/Group-group01.json
hl7.fhir.uv.cpg.r4R4Group/Group-chf-groupdefinition.json
hl7.fhir.uv.cpg.r4R4Group/Group-chf-scenario1-group.json
hl7.fhir.uv.ebmR6Group/Group-179619.jsonSystematicReviewEligibilityCriteria: ADT and Docetaxel vs. ADT alone for metastatic hormone-naive prostate canceractiveuvhl7
hl7.fhir.uv.ebmR6Group/Group-179897.jsonConceptualCohortDefinition: Estimated glomerular filtration rate 45-59activeuvhl7
hl7.fhir.uv.ebmR6Group/Group-172424.jsonConceptualComparatorDefinition: NOT Bariatric Surgery (RYGB, VSG, LAGB, BPD)activeuvhl7
hl7.fhir.uv.ebmR6Group/Group-264328.jsonSearch Strategy for NMA_Diabetesactiveuvhl7
hl7.fhir.uv.ebmR6Group/Group-172423.jsonConceptualExposureDefinition: Bariatric Surgery (RYGB, VSG, LAGB, BPD)activeuvhl7
hl7.fhir.uv.ebmR6Group/Group-179514.jsonConceptualCohortDefinition: BMI 27.5-32.4 in Asian Americans who do not achieve durable weight loss and improvement in comorbidities without surgeryactiveuvhl7
hl7.fhir.uv.ebmR6Group/Group-179513.jsonConceptualCohortDefinition: BMI 30-34.9 in persons who do not achieve durable weight loss and improvement in comorbidities without surgeryactiveuvhl7
hl7.fhir.uv.ebmR6Group/Group-179510.jsonConceptualCohortDefinition: BMI 32.5-37.4 in Asian Americans who do not achieve durable weight loss and improvement in comorbidities without surgeryactiveuvhl7
hl7.fhir.uv.ebmR6Group/Group-179509.jsonConceptualCohortDefinition: BMI 35-39.9 in persons who do not achieve durable weight loss and improvement in comorbidities without surgeryactiveuvhl7
hl7.fhir.uv.ebmR6Group/Group-179375.jsonConceptualCohortDefinition: Severe obesityactiveuvhl7
hl7.fhir.uv.ebmR6Group/Group-179376.jsonConceptualCohortDefinition: BMI ≥ 35 and at least 1 obesity-related comorbidityactiveuvhl7
hl7.fhir.uv.ebmR6Group/Group-179508.jsonConceptualCohortDefinition: BMI ≥ 37.5 kg/m2 in Asian Americansactiveuvhl7
hl7.fhir.uv.ebmR6Group/Group-179512.jsonConceptualCohortDefinition: Lower BMI criteria for ADA surgery considerationactiveuvhl7
hl7.fhir.uv.ebmR6Group/Group-179506.jsonConceptualCohortDefinition: BMI criteria for ADA surgery recommendationactiveuvhl7
hl7.fhir.uv.ebmR6Group/Group-170441.jsonConceptualCohortDefinition_Cancer_of_any_kind_except_basal_cell_skin_cancer_or_cancer_in_situ_unless_documented_to_be_disease_free_for_five_yearsactive2022-09uvhl7
hl7.fhir.uv.ebmR6Group/Group-170442.jsonConceptualCohortDefinition_Cardiovascular_eventactive2022-09uvhl7
hl7.fhir.uv.ebmR6Group/Group-179786.jsonConceptualExposureDefinition: Therapeutic-dose anticoagulation with heparinactiveuvhl7
hl7.fhir.uv.ebmR6Group/Group-179785.jsonConceptualComparatorDefinition: Usual-care pharmacologic thromboprophylaxisactiveuvhl7
hl7.fhir.uv.ebmR6Group/Group-173252.jsonOutcomeDefinition: Diabetes in remissionactiveuvhl7
hl7.fhir.uv.ebmR6Group/Group-179799.jsonMetaanalysisStudyGroup: Effect Estimates for Mortality at 14 days from COVID19 Remdesivir vs. Placebo RCTsactiveuvhl7
hl7.fhir.uv.ebmR6Group/Group-264323.jsonEligibility criteria for NMA_Diabetesactiveuvhl7
hl7.fhir.uv.ebmR6Group/Group-375279.jsonAdverse event free and hypertension controlactiveuvhl7
hl7.fhir.uv.ebmR6Group/Group-179593.jsonSearchStrategy: PubMed search for Wonder Womanactiveuvhl7
hl7.fhir.uv.ebmR6Group/Group-179507.jsonConceptualCohortDefinition: Proxy criteria for surgical candidatesactiveuvhl7
hl7.fhir.uv.ebmR6Group/Group-172484.jsonOutcomeDefinition: HbA1c at 12 monthsactiveuvhl7
hl7.fhir.uv.ebmR6Group/Group-172477.jsonOutcomeDefinition: HbA1c at 24 monthsactiveuvhl7
hl7.fhir.uv.ebmR6Group/Group-173245.jsonOutcomeDefinition: HbA1c at 36 monthsactiveuvhl7
hl7.fhir.uv.ebmR6Group/Group-175762.jsonOutcomeDefinition: HbA1c at 6 monthsactiveuvhl7
hl7.fhir.uv.ebmR6Group/Group-172476.jsonOutcomeDefinition: HbA1c at 60 monthsactiveuvhl7
hl7.fhir.uv.ebmR6Group/Group-367881.jsonNCT03640312 Eligibility Criteriaactiveuvhl7
hl7.fhir.uv.ebmR6Group/Group-267225.jsonNCT03421379 Eligibility Criteriaactiveuvhl7
hl7.fhir.uv.ebmR6Group/Group-583769.jsonNCT05327010 Eligibility Criteriaactiveuvhl7
hl7.fhir.uv.ebmR6Group/Group-189713.jsonNCT04401202 Eligibility Criteriaactiveuvhl7
hl7.fhir.uv.ebmR6Group/Group-175765.jsonMetaanalysisOutcomeDefinition: Mean difference in HbA1c between Surgery and Medical/Lifestyle groups at end of follow-upactiveuvhl7
hl7.fhir.uv.ebmR6Group/Group-279340.jsonConceptualCohortDefinition: Meet either T1DM-specific eligibility criteria or T2DM-specific eligibility criteriaactiveuvhl7
hl7.fhir.uv.ebmR6Group/Group-173251.jsonOutcomeDefinition: New onset depressionactiveuvhl7
hl7.fhir.uv.ebmR6Group/Group-173249.jsonConceptualCohortDefinition: Nonfatal myocardial infarctionactiveuvhl7
hl7.fhir.uv.ebmR6Group/Group-173250.jsonConceptualCohortDefinition: Nonfatal strokeactiveuvhl7
hl7.fhir.uv.ebmR6Group/Group-173248.jsonOutcomeDefinition: Nonfatal myocardial infarction or strokeactiveuvhl7
hl7.fhir.uv.ebmR6Group/Group-179562.jsonEvidenceReportSubject: Clinical Outcomes for Effects of Bariatric Surgeryactiveuvhl7
hl7.fhir.uv.ebmR6Group/Group-179783.jsonRemdesivir IV 200 mg once then 100 mg once daily for 9 daysactiveuvhl7
hl7.fhir.uv.ebmR6Group/Group-265092.jsonDiabetes treatment medicationactiveuvhl7
hl7.fhir.uv.ebmR6Group/Group-175766.jsonMetaanalysisEligibilityCriteria: Mean difference in HbA1c effect of bariatric surgery in type 2 diabetes and elevated BMI in 2016 meta-analysisactiveuvhl7
hl7.fhir.uv.ebmR6Group/Group-33395.jsonMetaanalysisStudyGroup: Study results included in Mean difference in HbA1c effect of bariatric surgery in 2016 meta-analysisactive2022-05uvhl7
hl7.fhir.uv.ebmR6Group/Group-172480.jsonOutcomeDefinition: American Diabetes Association composite triple end point for metabolic controlactiveuvhl7
hl7.fhir.uv.ebmR6Group/Group-236530.jsonComparatorDefinition: Standard careactiveuvhl7
hl7.fhir.uv.ebmR6Group/Group-236532.jsonInterventionDefinition: Glucagon-Like Peptide-1 (GLP-1) receptor agonistsactiveuvhl7
hl7.fhir.uv.ebmR6Group/Group-236533.jsonAdults with type 2 diabetes and established CVD (but no CKD)activeuvhl7
hl7.fhir.uv.ebmR6Group/Group-236769.jsonInterventionDefinition: Sodium-Glucose Transport Protein 2 (SGLT2) inhibitorsactiveuvhl7
hl7.fhir.uv.ebmR6Group/Group-236776.jsonComparatorDefinition: Glucagon-Like Peptide-1 (GLP-1) receptor agonistsactiveuvhl7
hl7.fhir.uv.ebmR6Group/Group-236947.jsonAdults with type 2 diabetes and CVD and CKDactiveuvhl7
hl7.fhir.uv.ebmR6Group/Group-282882.jsonNHANES LBXGLU Variable Definition Cohort Definitionactiveuvhl7
hl7.fhir.uv.ebmR6Group/Group-282891.jsonNHANES LBDGLUSI Variable Definition Cohort Definitionactiveuvhl7
hl7.fhir.uv.ebmR6Group/Group-282899.jsonNHANES WTSAF2YR Variable Definition Cohort Definitionactiveuvhl7
hl7.fhir.uv.ebmR6Group/Group-291368.jsonOutcomeDefinition: Mortality at 14 daysactiveuvhl7
hl7.fhir.uv.ebmR6Group/Group-346486.jsonCTIS2024-516402-32-00 Eligibility Criteriaactiveuvhl7
hl7.fhir.uv.ebmR6Group/Group-588218.jsonPICO: Intensive versus standard blood-pressure control for major adverse cardiovascular events in adults at increased cardiovascular riskactiveuvhl7
hl7.fhir.uv.ebmR6Group/Group-179633.jsonComparativeEvidenceReportSubject: Association of Bariatric Surgery vs Medical Obesity Treatment With Long-term Medical Complications and Obesity-Related Comorbidities (2018 Norwegian Cohort)activeuvhl7
hl7.fhir.uv.ebmR6Group/Group-179902.jsonConceptualCohortDefinition: At least 2 risk factors for strokeactiveuvhl7
hl7.fhir.uv.ebmR6Group/Group-297488.jsonJumping from aircraft with empty backpackactiveuvhl7
hl7.fhir.uv.ebmR6Group/Group-179584.jsonNetEffectContributions: Bariatric Surgery Example for GIN 2022activeuvhl7
hl7.fhir.uv.ebmR6Group/Group-297486.jsonJumping from aircraft with parachuteactiveuvhl7
hl7.fhir.uv.ebmR6Group/Group-297750.jsonOutcomeDefinition: Injury Severity Score on Impactactiveuvhl7